PyInvesting

Market research

ABBOTINDIA.NSE Abbott India Limited

NSE INR Healthcare

Latest close

26,525.00 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
567B
P/E ratio
34.74
Analyst target
31907.555
Dividend yield
0.0%
Beta
0.07

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Abbott India Limited is currently in a long term uptrend where the price is trading 11.8% above its 200 day moving average.

From a valuation standpoint, the stock is 60.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 7.7.

Abbott India Limited's total revenue rose by 1.6% to $11B since the same quarter in the previous year.

Its net income has dropped by 5.1% to $2B since the same quarter in the previous year.

Finally, its free cash flow fell by 6.0% to $3B since the same quarter in the previous year.

Based on the above factors, Abbott India Limited gets an overall score of 2/5.